ABSTRACT
Introduction ............................................................................................................ 342 Vaccine Targets ...................................................................................................... 342
Oncoproteins ..................................................................................................... 342 Oncofetal Antigens ............................................................................................344 Tissue-Specific Antigens and Other Overexpressed Proteins ........................... 345 Antigens Expressed by Cancer Stem Cells and Epithelial to Mesenchymal Transition ................................................................................... 345 Antigens Expressed by Tumor Vasculature ....................................................... 345
Vaccine Platforms ..................................................................................................346 Peptide and Protein Vaccines ............................................................................346 Dendritic Cell Vaccines .....................................................................................346 Anti-Idiotype Vaccines ......................................................................................346 Recombinant Vector Vaccines ...........................................................................346
